Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Signifor“
Suchtreffer
Begriffe & Kennungen
Signifor · 4.8 · Adverse reactions reported up to the cut-off date of the analysis are presented in Table 1. Adverse reactions
Eintrag öffnenSignifor · 4.8 · Cushing’s disease In Cushing’s disease patients, elevated FPG levels was the most frequently reported CTC Grad
Eintrag öffnenSignifor · 4.8 · Cushing’s disease In Cushing’s disease, the safety assessment of the intramuscular formulation was made based
Eintrag öffnenSignifor · 4.8 · Gastrointestinal disorders Gastrointestinal disorders were frequently reported with Signifor. These reactions
Eintrag öffnenSignifor · 4.8 · Gastrointestinal disorders Gastrointestinal disorders were frequently reported with Signifor. These reactions
Eintrag öffnenSignifor · 4.8 · Glucose metabolism disorders Acromegaly In acromegaly patients elevated fasting glucose level was the most fre
Eintrag öffnenSignifor · 4.8 · Glucose metabolism disorders Elevated glucose was the most frequently reported Grade 3 laboratory abnormality
Eintrag öffnenSignifor · 4.8 · Grade 1 and 2 adverse reactions were reported in 57.4% of patients. Grade 3 adverse reactions were observed in
Eintrag öffnenSignifor · 4.8 · Injection site reactions Injection site reactions were reported in 13.6% of patients enrolled in the phase III
Eintrag öffnenSignifor · 4.8 · Liver enzymes Transient elevations in liver enzymes have been reported with the use of somatostatin analogues
Eintrag öffnenSignifor · 4.8 · Liver enzymes Transient elevations in liver enzymes have been reported with the use of somatostatin analogues
Eintrag öffnenSignifor · 4.8 · Monitoring of blood glucose levels in patients treated with Signifor is recommended (see section 4.4).
Eintrag öffnenSignifor · 4.8 · Monitoring of blood glucose levels in patients treated with Signifor is recommended (see section 4.4).
Eintrag öffnenSignifor · 4.8 · Monitoring of liver enzymes is recommended before and during treatment with Signifor (see section 4.4), as cli
Eintrag öffnenSignifor · 4.8 · Monitoring of liver enzymes is recommended before and during treatment with Signifor (see section 4.4), as cli
Eintrag öffnenSignifor · 4.8 · Pancreatic enzymes Asymptomatic elevations in lipase and amylase were observed in patients receiving pasireoti
Eintrag öffnenSignifor · 4.8 · Pancreatic enzymes Asymptomatic elevations in lipase and amylase were observed in patients receiving pasireoti
Eintrag öffnenSignifor · 4.8 · QT prolongation In the acromegaly study C2305, the proportion of patients with newly occurring notable QT/QTc
Eintrag öffnenSignifor · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenSignifor · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnen